KRON – kronos bio, inc. (US:NASDAQ)
Stock Stats
News
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Kronos Bio Reports First-Quarter 2024 Financial Results [Yahoo! Finance]
Kronos Bio Reports First-Quarter 2024 Financial Results
Kronos Bio, Inc. (NASDAQ: KRON) had its price target lowered by analysts at HC Wainwright from $2.50 to $2.25. They now have a "buy" rating on the stock.
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Form 8-K Kronos Bio, Inc. For: May 09
Form 10-Q Kronos Bio, Inc. For: Mar 31
Form ARS Kronos Bio, Inc. For: Dec 31
Form DEFA14A Kronos Bio, Inc.
Form DEF 14A Kronos Bio, Inc. For: Jun 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.